(Q40107397)

English

Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

0 references

eradication of infectious diseases

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Annie George Chandy

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Merja Nurkkala

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Agnetha Josefsson

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Kristina Eriksson

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

8 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6037-6046

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Epidemiology of cancer: global patterns and trends

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Vaccine strategies for human papillomavirus-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Vaccination to prevent and treat cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

A Virus-based Vaccine May Prevent Cervical Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

A controlled trial of a human papillomavirus type 16 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

CD8 is needed for development of cytotoxic T cells but not helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Dendritic cell vaccination protects mice against lethality caused by genital herpes simplex virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Neurokinin 1 receptor signaling affects the local innate immune defense against genital herpes virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Cholera toxin indirectly activates human monocyte-derived dendritic cells in vitro through the production of soluble factors, including prostaglandin E(2) and nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Inhibitory effects of unmethylated CpG oligodeoxynucleotides on MHC class I-deficient and -proficient HPV16-associated tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

DNA Array and Biological Characterization of the Impact of the Maturation Status of Mouse Dendritic Cells on Their Phenotype and Antitumor Vaccination Efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Chemokines provide the sustained inflammatory bridge between innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Combined dendritic cell- and CpG oligonucleotide-based immune therapy cures large murine tumors that resist chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

MHC expression and chemokine production in the murine vagina following intra-vaginal administration of ligands to toll-like receptors 3, 7 and 9

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Of mice and not men: differences between mouse and human immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

The many roles of chemokines and chemokine receptors in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.05.041

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.05.041

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40107397&oldid=1885393451"